Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? One-Year Outcomes of Sentinel Node Biopsy Versus Axillary Clearance (SNAC): A Randomized Controlled Surgical Trial

[1]  C. Collins,et al.  The sentinel node in breast cancer , 2008, Cancer imaging : the official publication of the International Cancer Imaging Society.

[2]  J. Kollias,et al.  COMPARISON OF VOLUME DISPLACEMENT VERSUS CIRCUMFERENTIAL ARM MEASUREMENTS FOR LYMPHOEDEMA: IMPLICATIONS FOR THE SNAC TRIAL , 2008, ANZ journal of surgery.

[3]  M. Stockler,et al.  Comparing patients’ and clinicians’ assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial) , 2008, Breast Cancer Research and Treatment.

[4]  T. Julian,et al.  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. , 2007, The Lancet. Oncology.

[5]  J. Benson,et al.  Management of the axilla in women with breast cancer. , 2007, Breast.

[6]  Umberto Veronesi,et al.  Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. , 2006, The Lancet. Oncology.

[7]  H. Cody.  Sentinel Lymph Node Biopsy , 2006 .

[8]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[9]  Mazen M. Hashisho.  Sentinel Node Biopsy for Breast Cancer , 2006 .

[10]  R. Newcombe,et al.  Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer , 2006, Breast Cancer Research and Treatment.

[11]  M. Stockler,et al.  Participation in the RACS Sentinel Node Biopsy versus Axillary Clearance Trial , 2005, ANZ journal of surgery.

[12]  Gebski,et al.  Health-related quality of life (HRQL) before and 1 month after axillary surgery in a randomized trial of sentinel node (SN) biopsy versus axillary clearance (AC): the SNAC Trial. , 2004 .

[13]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[14]  V. Gebski,et al.  Randomisation in clinical trials , 2002, The Medical journal of Australia.

[15]  J. Boyages,et al.  Treatment implications of a positive sentinel lymph node biopsy for patients with early‐stage breast carcinoma , 2001, Cancer.

[16]  B. Cady.  Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients , 2001, Journal of surgical oncology.

[17]  C. Cox,et al.  The role of selective sentinel lymph node dissection in breast cancer. , 2000, The Surgical clinics of North America.

[18]  G. Farshid,et al.  Clinical and histological factors associated with sentinel node identification in breast cancer. , 2000, The Australian and New Zealand journal of surgery.

[19]  H. Cody,et al.  State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. , 1999, Surgical oncology.

[20]  R. Rubens,et al.  Management of early breast cancer. , 1992, BMJ.